The next phase of the pandemic is tricky because, generally speaking, everyone wants the best for youngsters and the health of the NEXTGEN has never before been subject to partisan slap fighting.
Here's the word from a local healthcare leader . . .
“The FDA is meeting on October 26,” said Dr. Angela Myers of Children’s Mercy Hospital, “and so this is exciting, to discuss and review the data for 5 to 11-year-olds.”
Not many people would call that exciting. Not many people have been living on the front lines of the pandemic the way the physicians at Children’s Mercy have.
The Pfizer vaccine for children is one-third the dosage size for adults, 10 ml. It is packaged in a different vial with different colors to differentiate it from its larger and stronger counterpart.
Read more via www.TonysKansasCity.com news link . . .
In a week, Pfizer will present new vaccine data to the United States Food and Drug Administration. They plan to ask for emergency use authorization of their COVID-19 vaccine for children between the ages of 5 and 11.